<qa>  What type of subjects will be indicated for nonemergent percutaneous treatment after heart team evaluation?The study population will consist of high risk subjects indicated for nonemergent percutaneous treatment after heart team evaluation including a cardiac surgeon of at least one de novo or restenotic lesion in a native coronary vessel or bypass graft. 